BiOWiSH Technologies is Multi-line Chemicals in United States that focus on pet health business. Founded in 2007. They cover business area such as developer, manufacturer, innovative product, biotechnology, mankind, natural biological process, food production, environmental management, human and pet health, proprietary non-GMO, naturally occur organism, their metabolite, various industrial and agricultural client, their process.
2007
( 17 years old in 2024 )
Pet Health
-
2717 Erie Avenue
Suite B
Cincinnati, OH 45208
United States
Private
developermanufacturerinnovative productbiotechnologymankindnatural biological processfood productionenvironmental managementhuman and pet healthproprietary non-GMOnaturally occur organismtheir metabolitevarious industrial and agricultural clienttheir process
* We use standard office opening hours in near BiOWiSH Technologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BiOWiSH Technologies is Multi-line Chemicals business from United States that founded in 2007 (17 years old in 2024), BiOWiSH Technologies business is focusing on Pet Health.
BiOWiSH Technologies headquarter office and corporate office address is located in 2717 Erie Avenue Suite B Cincinnati, OH 45208 United States.
BiOWiSH Technologies was founded in United States.
In 2024, BiOWiSH Technologies is currently focus on pet health sector.
Above is snippet of Google Trends for "pet health" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BiOWiSH Technologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
